ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,209Medicare Part D Prescriptions Filled, Including Refills

Rank: 154 out of 1107

$758K Total Retail Price of All Prescriptions

Rank: 183 out of 1107

842 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 842 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 842 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 8,462 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 536 288 1 2
OMEPRAZOLE 504 259 2 4
FUROSEMIDE 399 247 3 7
LEVOTHYROXINE SODIUM 399 288 3 3
HYDROCODONE-ACETAMINOPHEN 366 219 S3 5 1
MELOXICAM 330 201 6 25
METOPROLOL TARTRATE 315 175 7 10
PRAVASTATIN SODIUM 305 169 8 12
PREDNISONE 294 200 9 40
LOSARTAN POTASSIUM 287 209 10 29
GABAPENTIN 270 125 11 9
SIMVASTATIN 252 178 12 5
POTASSIUM CHLORIDE 247 174 13 14
METFORMIN HCL ER 234 142 14 58
CITALOPRAM HBR 227 119 15 17
FLUOXETINE HCL 220 60 16 47
HYDROCHLOROTHIAZIDE 219 135 17 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 107 18 24
METFORMIN HCL 182 130 19 8
LOVASTATIN 181 107 20 55
TRAZODONE HCL 168 71 21 33
NEXIUM 165 52 22 18
AMOXICILLIN 151 68 23 90
CIPROFLOXACIN HCL 145 68 24 59
WARFARIN SODIUM 144 110 25 15
CEFUROXIME 138 103 26 157
ZOLPIDEM TARTRATE 132 66 27 22
CARVEDILOL 129 70 28 27
AZITHROMYCIN 129 66 28 35
ATENOLOL 127 44 30 19
PROMETHAZINE HCL 127 42 R 30 44
PANTOPRAZOLE SODIUM 113 60 32 30
ATORVASTATIN CALCIUM 110 81 33 13
VENTOLIN HFA 109 53 34 97
AMLODIPINE BESYLATE 102 66 35 6
CYCLOBENZAPRINE HCL 101 18 R 36 56
ADVAIR DISKUS 100 62 37 54
TAMSULOSIN HCL 100 75 37 30
RANITIDINE HCL 100 78 37 21
PROAIR HFA 98 41 40 37
NAPROXEN 95 35 41 80
LANTUS 94 57 42 49
CLOPIDOGREL 88 61 43 28
QUETIAPINE FUMARATE 87 29 44 94
PAROXETINE HCL 86 28 45 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 85 61 46 88
LANSOPRAZOLE 84 31 47 102
MECLIZINE HCL 80 71 48 114
TRAMADOL HCL 80 57 48 26
ALLOPURINOL 79 49 50 36
ROPINIROLE HCL 76 44 51 69
METOPROLOL SUCCINATE 75 49 52 16
DICYCLOMINE HCL 70 32 53 208
OXYCODONE HCL-ACETAMINOPHEN 70 32 S2 53 93
TOPIRAMATE 69 12 55 160
POLYETHYLENE GLYCOL 3350 69 39 55 46
SERTRALINE HCL 68 48 57 20
OXYCODONE-ACETAMINOPHEN 68 37 S2 57 104
NITROFURANTOIN MONO-MACRO 68 48 57 207
SYMBICORT 66 47 60 124
FLUTICASONE PROPIONATE 65 27 61 38
LOSARTAN-HYDROCHLOROTHIAZIDE 63 41 62 66
CEPHALEXIN 60 43 63 81
JANUVIA 58 40 64 60
VERAPAMIL ER 58 24 64 113
METHOCARBAMOL 58 14 R 64 142
TIZANIDINE HCL 57 0 67 73
PLAVIX 57 42 67 39
MUPIROCIN 56 26 69 161
FENOFIBRATE 54 26 70 67
CLONIDINE HCL 54 15 70 53
NAMENDA 54 46 70 42
ESTRADIOL 53 0 R 73 151
COMBIVENT 53 44 73 112
CRESTOR 52 18 75 23
IBUPROFEN 52 13 75 63
OXYCODONE HCL 52 23 S2 75 100
FLUCONAZOLE 51 28 78 150
OXYBUTYNIN CHLORIDE ER 51 42 78 179
GLIPIZIDE 51 36 78 64
ALENDRONATE SODIUM 50 35 81 41
SPIRIVA 50 36 81 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.